On Tuesday, CureVac N.V. (NASDAQ: CVAC) was -3.02% drop from the session before settling in for the closing price of $2.98. A 52-week range for CVAC has been $2.21 – $6.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 54.58%. When this article was written, the company’s average yearly earnings per share was at 144.16%. With a float of $93.63 million, this company’s outstanding shares have now reached $223.99 million.
Let’s determine the extent of company efficiency that accounts for 1172 employees. In terms of profitability, gross margin is -162.37%, operating margin of -447.48%, and the pretax margin is -419.92%.
CureVac N.V. (CVAC) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CureVac N.V. stocks. The insider ownership of CureVac N.V. is 58.26%, while institutional ownership is 6.46%. The most recent insider transaction that took place on Sep 27 ’24, was worth 169. Before that another transaction happened on Sep 25 ’24, when Company’s affiliate proposed sale 34,000 for $3.10, making the entire transaction worth $105,400.
CureVac N.V. (CVAC) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 144.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.76% during the next five years compared to -23.15% drop over the previous five years of trading.
CureVac N.V. (NASDAQ: CVAC) Trading Performance Indicators
You can see what CureVac N.V. (CVAC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit 1.57 in the next quarter and is forecasted to reach -0.48 in one year’s time.
Technical Analysis of CureVac N.V. (CVAC)
Looking closely at CureVac N.V. (NASDAQ: CVAC), its last 5-days average volume was 0.38 million, which is a drop from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 27.50%. Additionally, its Average True Range was 0.17.
During the past 100 days, CureVac N.V.’s (CVAC) raw stochastic average was set at 7.54%, which indicates a significant increase from 3.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.37% in the past 14 days, which was lower than the 75.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.19, while its 200-day Moving Average is $3.37. However, in the short run, CureVac N.V.’s stock first resistance to watch stands at $2.98. Second resistance stands at $3.07. The third major resistance level sits at $3.12. If the price goes on to break the first support level at $2.84, it is likely to go to the next support level at $2.79. Should the price break the second support level, the third support level stands at $2.70.
CureVac N.V. (NASDAQ: CVAC) Key Stats
There are 223,880K outstanding shares of the company, which has a market capitalization of 648.26 million. As of now, sales total 58,180 K while income totals -281,580 K. Its latest quarter income was 15,550 K while its last quarter net income were -78,120 K.
